HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIF-1α-dependent miR-424 induction confers cisplatin resistance on bladder cancer cells through down-regulation of pro-apoptotic UNC5B and SIRT4
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 39, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-06-10
DOI
10.1186/s13046-020-01613-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New combinatorial strategies to improve the PARP inhibitors efficacy in the urothelial bladder Cancer treatment
- (2019) Daniela Criscuolo et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- CCDC6 and USP7 expression levels suggest novel treatment options in high-grade urothelial bladder cancer
- (2019) Francesco Morra et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- miR424-5p functions as an anti-oncogene in cervical cancer cell growth by targeting KDM5B via the Notch signaling pathway
- (2017) Yan Zhou et al. LIFE SCIENCES
- Contemporary update on neoadjuvant therapy for bladder cancer
- (2017) Daniel P. Nguyen et al. Nature Reviews Urology
- Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancer
- (2016) Fuquan Zhang et al. CANCER SCIENCE
- MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression
- (2016) Cecilia Dallavalle et al. JOURNAL OF CLINICAL INVESTIGATION
- The ever-expanding role of HIF in tumour and stromal biology
- (2016) Edward L. LaGory et al. NATURE CELL BIOLOGY
- Systemic, perioperative management of muscle-invasive bladder cancer and future horizons
- (2016) Samuel A. Funt et al. Nature Reviews Clinical Oncology
- Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
- (2016) Caroline Wigerup et al. PHARMACOLOGY & THERAPEUTICS
- miR-424-5p promotes proliferation of gastric cancer by targeting Smad3 through TGF-β signaling pathway
- (2016) Song Wei et al. Oncotarget
- SIRT4 regulates ATP homeostasis and mediates a retrograde signaling via AMPK
- (2016) Linh Ho et al. Aging-US
- Hypoxia-induced chemoresistance in cancer cells: The role of not only HIF-1
- (2015) Helena Doktorova et al. BIOMEDICAL PAPERS-OLOMOUC
- Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma
- (2015) Guoyu Huang et al. BIOMEDICINE & PHARMACOTHERAPY
- Tumour-suppressive function of SIRT4 in human colorectal cancer
- (2015) M Miyo et al. BRITISH JOURNAL OF CANCER
- TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation
- (2015) D. J. Drasin et al. CANCER RESEARCH
- Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
- (2015) Haiquan Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNA-424 Is Down-Regulated in Hepatocellular Carcinoma and Suppresses Cell Migration and Invasion through c-Myb
- (2014) Lei Yu et al. PLoS One
- Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells
- (2014) Debangshu Samanta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Hypoxia-induced miR-424 decreases tumor sensitivity to chemotherapy by inhibiting apoptosis
- (2014) D Zhang et al. Cell Death & Disease
- MiR-424-5p reversed epithelial-mesenchymal transition of anchorage-independent HCC cells by directly targeting ICAT and suppressed HCC progression
- (2014) Ying Zhang et al. Scientific Reports
- Hypoxia-regulated microRNAs in human cancer
- (2013) Guomin Shen et al. ACTA PHARMACOLOGICA SINICA
- SIRT4 Has Tumor-Suppressive Activity and Regulates the Cellular Metabolic Response to DNA Damage by Inhibiting Mitochondrial Glutamine Metabolism
- (2013) Seung Min Jeong et al. CANCER CELL
- Tumor Cells Upregulate Normoxic HIF-1 in Response to Doxorubicin
- (2013) Y. Cao et al. CANCER RESEARCH
- SIRT4 Protein Suppresses Tumor Formation in Genetic Models of Myc-induced B Cell Lymphoma
- (2013) Seung Min Jeong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study
- (2013) T. Berghmans et al. LUNG CANCER
- Regulation of epithelial plasticity by miR-424 and miR-200 in a new prostate cancer metastasis model
- (2013) Jacqueline Banyard et al. Scientific Reports
- Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
- (2012) Gregg L. Semenza TRENDS IN PHARMACOLOGICAL SCIENCES
- The Dependence Receptor UNC5H2/B Triggers Apoptosis via PP2A-Mediated Dephosphorylation of DAP Kinase
- (2010) Céline Guenebeaud et al. MOLECULAR CELL
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started